oxazolidin-2-one has been researched along with Co-infection in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 9 (90.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Roch, M; Rosato, AE; Taglialegna, A; Varela, MC | 1 |
Boulle, A; Fox, T; Khomo, N; Kock, Y; Leslie, J; Manning, K; Meintjes, G; Mudaly, V; Stewart, A; Tiffin, N; Wasserman, S; Zhao, Y | 1 |
Fusco, DN; He, Y; Liu, X; Papanicolaou, GA; White, JR; Xiao, K | 1 |
Davis, JG; Farley, J; Lancaster, J; Odendaal, R; Shean, K; Van der Walt, M | 1 |
Deshpande, LM; Jones, RN; Kim, J; Mendes, RE; Myers, DS; Ross, JE | 1 |
Birket, SE; Breslow-Deckman, JM; Feola, DJ; Garvy, BA; Ho, TN; Hoskins, SN; Mattingly, CM | 1 |
Andreacchio, KA; Cárdenas, AM; Edelstein, PH | 1 |
Al-Nawas, B; d'Hoedt, B; Karbach, J; Mouratidou, A | 1 |
Bragagnolo, L; Cornaglia, G; Kocsis, E; Mazzariol, A; Pellizzer, G; Rassu, M | 1 |
Hallbauer, UM; Hesseling, AC; Rose, PC; Schaaf, HS; Seddon, JA | 1 |
10 other study(ies) available for oxazolidin-2-one and Co-infection
Article | Year |
---|---|
Tedizolid is a promising antimicrobial option for the treatment of Staphylococcus aureus infections in cystic fibrosis patients.
Topics: Adult; Animals; Anti-Bacterial Agents; Child; Coinfection; Cystic Fibrosis; Humans; Larva; Mice; Microbial Sensitivity Tests; Moths; Oxazolidinones; Pneumonia, Bacterial; Protein Synthesis Inhibitors; Sputum; Staphylococcal Infections; Staphylococcus aureus; Tetrazoles; Whole Genome Sequencing | 2020 |
Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort Study.
Topics: Adult; Antitubercular Agents; Coinfection; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Female; HIV; HIV Infections; Humans; Isoniazid; Isoxazoles; Levofloxacin; Male; Mycobacterium tuberculosis; Oxazolidinones; Pyrazinamide; Retrospective Studies; South Africa; Survival Analysis; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2019 |
Effect of linezolid on clinical severity and pulmonary cytokines in a murine model of influenza A and Staphylococcus aureus coinfection.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Load; Coinfection; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Immunologic Factors; Influenza A virus; Influenza, Human; Interleukins; Linezolid; Lung; Mice; Mice, Inbred C57BL; Oxazolidinones; Severity of Illness Index; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Viral Load; Weight Loss | 2013 |
Serious treatment related adverse drug reactions amongst anti-retroviral naïve MDR-TB patients.
Topics: Adult; Antitubercular Agents; Coinfection; Cycloserine; Drug Resistance, Multiple, Bacterial; Female; Hearing Loss; HIV Infections; Humans; Isoxazoles; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Oxazolidinones; Prospective Studies; Psychoses, Substance-Induced; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2013 |
Streptococcus sanguinis isolate displaying a phenotype with cross-resistance to several rRNA-targeting agents.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Coinfection; Drug Resistance, Bacterial; Endocarditis, Bacterial; Humans; Linezolid; Male; Mutation, Missense; Oxazolidinones; Phenotype; Point Mutation; Ribosomal Proteins; RNA, Ribosomal, 23S; Staphylococcal Infections; Staphylococcus epidermidis; Streptococcal Infections; Streptococcus | 2013 |
Linezolid decreases susceptibility to secondary bacterial pneumonia postinfluenza infection in mice through its effects on IFN-γ.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Load; Bronchoalveolar Lavage Fluid; CD4 Lymphocyte Count; Coinfection; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Influenza A virus; Interferon-gamma; Linezolid; Lung; Mice; Mice, Inbred C57BL; Orthomyxoviridae Infections; Oxazolidinones; Pneumonia, Pneumococcal; Recombinant Proteins; Tumor Necrosis Factor-alpha; Viral Load; Virus Replication | 2013 |
Prevalence and detection of mixed-population enterococcal bacteremia.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Bacteremia; Coinfection; Daptomycin; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Multilocus Sequence Typing; Oxazolidinones; Prevalence; Treatment Outcome; Vancomycin Resistance | 2014 |
Antibiotic susceptibility of cocultures in polymicrobial infections such as peri-implantitis or periodontitis: an in vitro model.
Topics: Acetamides; Actinobacillus Infections; Aggregatibacter actinomycetemcomitans; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Capnocytophaga; Coculture Techniques; Coinfection; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Metronidazole; Microbial Interactions; Minocycline; Moxifloxacin; Oxazolidinones; Penicillin G; Peptostreptococcus; Peri-Implantitis; Periodontitis; Quinolines; Sulbactam | 2011 |
Co-infection by two linezolid-resistant coagulase-negative staphylococci with two different resistance determinants.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Coagulase; Coinfection; Drug Resistance, Bacterial; Humans; Italy; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Point Mutation; RNA, Ribosomal, 23S; Staphylococcal Infections; Staphylococcus | 2012 |
Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
Topics: Acetamides; Adolescent; Age Factors; Anti-HIV Agents; Antitubercular Agents; Child; Child, Preschool; Coinfection; Cost Savings; Drug Costs; Drug Interactions; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; HIV Infections; Humans; Infant; Linezolid; Male; Mycobacterium tuberculosis; Oxazolidinones; Retrospective Studies; South Africa; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2012 |